Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 31-40 of 53 (Search time: 0.003 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2008Re: Excess of early onset multiple myeloma in endometrial cancer probands and their relatives suggests common susceptibilitySpurdle, A.; Webb, P.; Oehler, M.
2003The prevalence of pelvic floor disorders and their relationship to gender, age and mode of delivery - replyMacLennan, A.; Taylor, A.; Wilson, D.; Wilson, D.
1999The relationship between 6-sulphatoxymelatonin and polysomnographic sleep in good sleeping controls and wake maintenance insomniacs, aged 55-80 yearsLushington, K.; Dawson, D.; Kennaway, D.; Lack, L.
2008Metabolic effects of weight loss on a very-low-carbohydrate diet compared with an isocaloric high-carbohydrate diet in abdominally obese subjectsTay, J.; Brinkworth, G.; Noakes, M.; Keogh, J.; Clifton, P.
1999Urinary 6-sulfatoxymelatonin excretion and aging: New results and a critical review of the literatureKennaway, D.; Lushington, K.; Dawson, D.; Lack, L.; van den Heuvel, C.; Rogers, N.
2000The prevalence of pelvic floor disorders and their relationship to gender, age, parity and mode of deliveryMacLennan, A.; Taylor, A.; Wilson, D.; Wilson, D.
2007Main morbidities recorded in the women's international study of long duration oestrogen after menopause (WISDOM): a randomised controlled trial of hormone replacement therapy in postmenopausal womenVickers, M.; MacLennan, A.; Lawton, B.; Ford, D.; Martin, J.; Meredith, S.; De Stavola, B.; Rose, S.; Dowell, A.; Wilkes, H.; Darbyshire, J.; Meade, T.
2012Randomized, double-blind, placebo-controlled phase II study of AMG 386 combined with weekly paclitaxel in patients with recurrent ovarian cancerKarlan, B.; Oza, A.; Richardson, G.; Provencher, D.; Hansen, V.; Buck, M.; Chambers, S.; Ghatage, P.; Pippitt Jr, C.; Brown III, J.; Covens, A.; Nagarkar, R.; Davy, M.; Leath III, C.; Nguyen, H.; Stepan, D.; Weinreich, D.; Tassoudji, M.; Sun, Y.; Vergote, I.
2004Expression of extracellular matrix components versican, chondroitin sulfate, tenascin, and hyaluronan, and their association with disease outcome in node-negative breast cancerSuwiwat, S.; Ricciardelli, C.; Tammi, R.; Tammi, M.; Auvinen, P.; Kosma, V.; LeBaron, R.; Raymond, W.; Tilley, W.; Horsfall, D.
2008Health related quality of life after combined hormone replacement therapy: randomised controlled trialWelton, A.; Vickers, M.; Kim, J.; Ford, D.; Lawton, B.; MacLennan, A.; Meredith, S.; Martin, J.; Meade, T.